Hormonal testing and pharmacologic treatment of erectile dysfunction: A clinical practice guideline from the American College of Physicians

Annals of Internal Medicine

Volumn 151, Issue 9, 2009, Pages 639-649

  Qaseem, Amir ^a   Snow, Vincenza ^a   Denberg, Thomas D ^b   Casey, Donald E ^c   Forciea, Mary Ann ^c   Owens, Douglas K ^c   Shekelle, Paul ^c  

^a AMERICAN COLLEGE OF PHYSICIANS   (United States)

^b Academic Office 1   (United States)

^c NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALFUZOSIN; APOMORPHINE; ATORVASTATIN; CABERGOLINE; DIHYDROERGOTAMINE; MIRODENAFIL; PHENTOLAMINE; PHOSPHODIESTERASE V INHIBITOR; PLACEBO; PROLACTIN; PROSTATE SPECIFIC ANTIGEN; QUINAPRIL; SILDENAFIL; TADALAFIL; TESTOSTERONE; UDENAFIL; UNCLASSIFIED DRUG; VARDENAFIL;

CLINICAL PRACTICE; CREAM; DIAGNOSTIC TEST; DIARRHEA; DIZZINESS; DRUG CHOICE; DRUG COST; DRUG DOSE COMPARISON; DRUG EFFICACY; DRUG FORMULATION; DRUG INDICATION; DRUG SAFETY; DYSPEPSIA; ENZYME INHIBITION; ERECTILE DYSFUNCTION; EVIDENCE BASED MEDICINE; FLUSHING; GEL; HEADACHE; HORMONAL THERAPY; HORMONE BLOOD LEVEL; HUMAN; HYPERPROLACTINEMIA; HYPOGONADISM; ISCHEMIC OPTIC NEUROPATHY; MALE; MEDICAL LITERATURE; MYALGIA; NAUSEA; NONARTERITIC ANTERIOR ISCHEMIC OPTIC NEUROPATHY; PENIS ERECTION; PHYSICIAN; POSITIVE END EXPIRATORY PRESSURE; POSTMARKETING SURVEILLANCE; PRACTICE GUIDELINE; PRIAPISM; PRIORITY JOURNAL; PROLACTIN BLOOD LEVEL; PSYCHOTHERAPY; RANDOMIZED CONTROLLED TRIAL; REVIEW; RHINITIS; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; SEXUAL INTERCOURSE; SIDE EFFECT; TESTOSTERONE BLOOD LEVEL; THORAX PAIN; TREATMENT OUTCOME; UNITED STATES; UNSPECIFIED SIDE EFFECT; VISUAL DISORDER; VOMITING;

CYCLIC NUCLEOTIDE PHOSPHODIESTERASES, TYPE 5; ERECTILE DYSFUNCTION; HORMONE REPLACEMENT THERAPY; HUMANS; HYPERPROLACTINEMIA; HYPOGONADISM; MALE; PENILE ERECTION; PROLACTIN; TESTOSTERONE;

EID: 70450210454     PISSN: 00034819     EISSN: 15393704     Source Type: Journal    
DOI: 10.7326/0000605-200911030-00151     Document Type: Review

References (202)

1. NIH Consensus Conference. Impotence. NIH Consensus Development Panel on Impotence. JAMA. 1993;270:83-90. [PMID: 8510302]
2. Feldman HA, Goldstein I, Hatzichristou DG, Krane RJ, McKinlay JB. Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study. J Urol. 1994;151:54-61. [PMID: 8254833] (Pubitemid 24046934)
3. Virag R. Indications and early results of sildenafil (Viagra) in erectile dysfunction. Urology. 1999;54:1073-1077 [PMID: 10604711]
4. Johannes CB, Araujo AB, Feldman HA, Derby CA, Kleinman KP, McKinlay JB. Incidence of erectile dysfunction in men 40 to 69 years old: longitudinal results from the Massachusetts male aging study. J Urol. 2000;163:460-463 [PMID: 10647654]
5. Tsertsvadze A, Yazdi F, Fink HA, MacDonald R, Wilt TJ, Soares-Weiser K, et al. Diagnosis and Treatment of Erectile Dysfunction. AHRQ Evidence Report/ Technology Assessment no. 171. Bethesda, MD: Agency for Healthcare Research and Quality; May 2009. AHRQ publication no. 08(09)-E016. Accessed at www.ahrq.gov/downloads/pub/evidence/pdf/erectiledys/erecdys.pdf on 26 May 2009.
6. Ayta IA, McKinlay JB, Krane RJ. The likely worldwide increase in erectile dysfunction between 1995 and 2025 and some possible policy consequences. BJU Int. 1999;84:50-56 [PMID: 10444124]
7. Wessells H, Joyce GF, Wise M, Wilt TJ. Erectile dysfunction. J Urol. 2007;177:1675-1681 [PMID: 17437781]
8. Tsertsvadze A, Fink HA, Yazdi F, MacDonald R, Bella AJ, Ansari MT, et al. Oral phosphodiesterase-5 inhibitors and hormonal treatments for erectile dysfunction: a systematic review and meta-analysis. Ann Intern Med. 2009;151:650-661
9. Johnson AR 3rd, Jarow JP. Is routine endocrine testing of impotent men necessary? J Urol. 1992;147:1542-3; discussion 1543-1544 [PMID: 1593685]
10. Buvat J, Lemaire A. Endocrine screening in 1,022 men with erectile dysfunction: clinical significance and cost-effective strategy. J Urol. 1997;158:1764-1767 [PMID: 9334596] (Pubitemid 27433148)
11. Citron JT, Ettinger B, Rubinoff H, Ettinger VM, Minkoff J, Hom F, et al. Prevalence of hypothalamic-pituitary imaging abnormalities in impotent men with secondary hypogonadism. J Urol. 1996;155:529-533 [PMID: 8558653] (Pubitemid 26023538)
12. Hatzichristou D, Hatzimouratidis K, Bekas M, Apostolidis A, Tzortzis V, Yannakoyorgos K. Diagnostic steps in the evaluation of patients with erectile dysfunction. J Urol. 2002;168:615-620 [PMID: 12131320] (Pubitemid 34793308)
13. Martin-Morales A, Meijide F, García N, Artes M, Muñoz A. Efficacy of vardenafil and influence on self-esteem and self-confidence in patients with severe erectile dysfunction. J Sex Med. 2007;4:440-447 [PMID: 17367439] (Pubitemid 46394717)
14. Acar D, Cayan S, Bozlu M, Akbay E. Is routine hormonal measurement necessary in initial evaluation of men with erectile dysfunction? Arch Androl. 2004;50:247-253 [PMID: 15277002]
15. Earle CM, Stuckey BG. Biochemical screening in the assessment of erectile dysfunction: what tests decide future therapy? Urology. 2003;62:727-731 [PMID: 14550452]
16. Rhoden EL, Telöken C, Mafessoni R, Souto CA. Is there any relation between serum levels of total testosterone and the severity of erectile dysfunction? Int J Impot Res. 2002;14:167-171 [PMID: 12058243]
17. Rhoden EL, Telöken C, Sogari PR, Souto CA. The relationship of serum testosterone to erectile function in normal aging men. J Urol. 2002;167:1745-1748 [PMID: 11912401] (Pubitemid 34240718)
18. Bunch TJ, Abraham D, Wang S, Meikle AW. Pituitary radiographic abnormalities and clinical correlates of hypogonadism in elderly males presenting with erectile dysfunction. Aging Male. 2002;5:38-46. [PMID: 12040974] (Pubitemid 34587556)
19. Fahmy AK, Mitra S, Blacklock AR, Desai KM. Is the measurement of serum testosterone routinely indicated in men with erectile dysfunction? BJU Int. 1999; 84:482-484 [PMID: 10468766]
20. Akpunonu BE, Mutgi AB, Federman DJ, York J, Woldenberg LS. Routine prolactin measurement is not necessary in the initial evaluation of male impotence. J Gen Intern Med. 1994;9:336-338 [PMID: 8077999] (Pubitemid 24188414)
21. Drinka PJ, Voeks S, Bauwens S, Binkley N. Sensitivity and positive predictive value of clinical signs of hypogonadism in elderly men. South Med J. 1993; 86:1264-1265 [PMID: 8235781] (Pubitemid 23345686)
22. El-Sakka AI, Hassoba HM, Sayed HM, Tayeb KA. Pattern of endocrinal changes in patients with sexual dysfunction. J Sex Med. 2005;2:551-558 [PMID: 16422853]
23. Tsujimura A, Matsumiya K, Miyagawa Y, Takao T, Fujita K, Takada S, et al. Comparative study on evaluation methods for serum testosterone level for PADAM diagnosis. Int J Impot Res. 2005;17:259-263 [PMID: 15616608] (Pubitemid 40675509)
24. Guay AT, Bansal S, Hodge MB. Possible hypothalamic impotence. Male counterpart to hypothalamic amenorrhea? Urology. 1991;38:317-322 [PMID: 1755138]
25. Forsberg L, Gustavii B, Höjerback T, Nilsson A, Olsson AM. One hundred impotent men. Scand J Urol Nephrol. 1990;24:83-87 [PMID: 2356457]
26. Reyes-Vallejo L, Lazarou S, Morgentaler A. Subjective sexual response to testosterone replacement therapy based on initial serum levels of total testosterone. J Sex Med. 2007;4:1757-1762 [PMID: 17087806] (Pubitemid 47616869)
27. El-Sakka AI, Hassoba HM. Age related testosterone depletion in patients with erectile dysfunction. J Urol. 2006;176:2589-2593 [PMID: 17085165]
28. Low WY, Khoo EM, Tan HM, Hew FL, Teoh SH. Depression, hormonal status and erectile dysfunction in the aging male: results from a community study in Malaysia. J Mens Health Gend. 2006;3:263-270 (Pubitemid 44389842)
29. Guay A, Jacobson J. The relationship between testosterone levels, the metabolic syndrome (by two criteria), and insulin resistance in a population of men with organic erectile dysfunction. J Sex Med. 2007;4:1046-1055 [PMID: 17627749] (Pubitemid 47079638)
30. Zohdy W, Kamal EE, Ibrahim Y. Androgen deficiency and abnormal penile duplex parameters in obese men with erectile dysfunction. J Sex Med. 2007;4: 797-808. [PMID: 17498110] (Pubitemid 46779317)
31. Araujo AB, Esche GR, Kupelian V, O'Donnell AB, Travison TG, Williams RE, et al. Prevalence of symptomatic androgen deficiency in men. J Clin Endocrinol Metab. 2007;92:4241-4247 [PMID: 17698901] (Pubitemid 350074738)
32. Kupelian V, Shabsigh R, Travison TG, Page ST, Araujo AB, McKinlay JB. Is there a relationship between sex hormones and erectile dysfunction? Results from the Massachusetts Male Aging Study. J Urol. 2006;176:2584-2588 [PMID: 17085164] (Pubitemid 44665980)
33. El-Sakka AI. Association of risk factors and medical comorbidities with male sexual dysfunctions. J Sex Med. 2007;4:1691-1700 [PMID: 17081221]
34. Makhlouf AA, Mohamed MA, Seftel AD, Niederberger C, Neiderberger C. Hypogonadism is associated with overt depression symptoms in men with erectile dysfunction. Int J Impot Res. 2008;20:157-161 [PMID: 17703222]
35. Köhler TS, Kim J, Feia K, Bodie J, Johnson N, Makhlouf A, et al. Prevalence of androgen deficiency in men with erectile dysfunction. Urology. 2008;71: 693-697 [PMID: 18313109]
36. Corona G, Mannucci E, Fisher AD, Lotti F, Petrone L, Balercia G, et al. Low levels of androgens in men with erectile dysfunction and obesity. J Sex Med. 2008;5:2454-2463 [PMID: 18494771]
37. Müezzinoǧu T, Gümüş B, Temeltaş G, Ari Z, Büyüksu C. A relationship of sex hormone levels and erectile dysfunction: which tests should be done routinely? Yonsei Med J. 2007;48:1015-1019 [PMID: 18159595]
38. Netto Júnior NR, Claro Jde A. The importance of hyperprolactinemia in impotence. Rev Paul Med. 1993;111:454-455 [PMID: 8052792]
39. Palmer JS, Kaplan WE, Firlit CF. Erectile dysfunction in patients with spina bifida is a treatable condition. J Urol. 2000;164:958-961 [PMID: 10958716]
40. Seidman SN, Roose SP, Menza MA, Shabsigh R, Rosen RC. Treatment of erectile dysfunction in men with depressive symptoms: results of a placebo-controlled trial with sildenafil citrate. Am J Psychiatry. 2001;158:1623-1630 [PMID: 11578994] (Pubitemid 32923654)
41. Kongkanand A, Ratana-Olarn K, Ruangdilokrat S, Tantiwong A; Thai investigators in ASSESS-2 Study Group. The efficacy and safety of oral sildenafil in Thai men with erectile dysfunction: a randomized, double-blind, placebo controlled, flexible-dose study. J Med Assoc Thai. 2003;86:195-205. [PMID: 12757058] (Pubitemid 36781940)
42. Stuckey BG, Jadzinsky MN, Murphy LJ, Montorsi F, Kadioglu A, Fraige F, et al. Sildenafil citrate for treatment of erectile dysfunction in men with type 1 diabetes: results of a randomized controlled trial. Diabetes Care. 2003;26:279-284 [PMID: 12547849] (Pubitemid 36929043)
43. Choi HK, Ahn TY, Kim JJ, Kim SC, Paick JS, Suh JK, et al. A doubleblind, randomised- placebo, controlled, parallel group, multicentre, flexible-dose escalation study to assess the efficacy and safety of sildenafil administered as required to male outpatients with erectile dysfunction in Korea. Int J Impot Res. 2003;15:80-86 [PMID: 12789384]
44. Levinson IP, Khalaf IM, Shaeer KZ, Smart DO. Efficacy and safety of sildenafil citrate (Viagra) for the treatment of erectile dysfunction in men in Egypt and South Africa. Int J Impot Res. 2003;15 Suppl 1:S25-9. [PMID: 12825106]
45. DeBusk RF, Pepine CJ, Glasser DB, Shpilsky A, DeRiesthal H, Sweeney M. Efficacy and safety of sildenafil citrate in men with erectile dysfunction and stable coronary artery disease. Am J Cardiol. 2004;93:147-153 [PMID: 14715338] (Pubitemid 38058721)
46. Boolell M, Gepi-Attee S, Gingell JC, Allen MJ. Sildenafil, a novel effective oral therapy for male erectile dysfunction. Br J Urol. 1996;78:257-261 [PMID: 8813924] (Pubitemid 27407907)
47. Goldstein I, Lue TF, Padma-Nathan H, Rosen RC, Steers WD, Wicker PA. Oral sildenafil in the treatment of erectile dysfunction. Sildenafil Study Group. N Engl J Med. 1998;338:1397-1404 [PMID: 9580646]
48. Tan HM, Moh CL, Mendoza JB, Gana T, Albano GJ, de la Cruz R, et al. Asian sildenafil efficacy and safety study (ASSESS-1): a double-blind, placebocontrolled, flexible-dose study of oral sildenafil in Malaysian, Singaporean, and Filipino men with erectile dysfunction. The Assess-1 Study Group. Urology. 2000;56:635-640 [PMID: 11018621]
49. Meuleman E, Cuzin B, Opsomer RJ, Hartmann U, Bailey MJ, Maytom MC, et al. A dose-escalation study to assess the efficacy and safety of sildenafil citrate in men with erectile dysfunction. BJU Int. 2001;87:75-81. [PMID: 11121996] (Pubitemid 32064025)
50. Eardley I, Morgan R, Dinsmore W, Yates P, Boolell M. Efficacy and safety of sildenafil citrate in the treatment of men with mild to moderate erectile dysfunction. Br J Psychiatry. 2001;178:325-330 [PMID: 11282811] (Pubitemid 32280926)
51. Young JM, Bennett C, Gilhooly P, Wessells H, Ramos DE. Efficacy and safety of sildenafil citrate (Viagra) in black and Hispanic American men. Urology. 2002;60:39-48. [PMID: 12414332] (Pubitemid 35300145)
52. Nurnberg HG, Hensley PL, Gelenberg AJ, Fava M, Lauriello J, Paine S. Treatment of antidepressant-associated sexual dysfunction with sildenafil: a randomized controlled trial. JAMA. 2003;289:56-64. [PMID: 12503977] (Pubitemid 36026278)
53. Price DE, Gingell JC, Gepi-Attee S, Wareham K, Yates P, Boolell M. Sildenafil: study of a novel oral treatment for erectile dysfunction in diabetic men. Diabet Med. 1998;15:821-825 [PMID: 9796881] (Pubitemid 28451950)
54. Rendell MS, Rajfer J, Wicker PA, Smith MD. Sildenafil for treatment of erectile dysfunction in men with diabetes: a randomized controlled trial. Sildenafil Diabetes Study Group. JAMA. 1999;281:421-426 [PMID: 9952201]
55. Christiansen E, Guirguis WR, Cox D, Osterloh IH; Sildenafil Multicentre Study Group. Long-term efficacy and safety of oral Viagra (sildenafil citrate) in men with erectile dysfunction and the effect of randomised treatment withdrawal. Int J Impot Res. 2000;12:177-182 [PMID: 11045912]
56. Olsson AM, Speakman MJ, Dinsmore WW, Giuliano F, Gingell C, Maytom M, et al; Sildenafil Multicentre Study Group. Sildenafil citrate (Viagra) is effective and well tolerated for treating erectile dysfunction of psychogenic or mixed aetiology. Int J Clin Pract. 2000;54:561-566 [PMID: 11220982]
57. Chen KK, Hsieh JT, Huang ST, Jiaan DB, Lin JS, Wang CJ; ASSESS-3 Study Group. ASSESS-3: a randomised, double-blind, flexible-dose clinical trial of the efficacy and safety of oral sildenafil in the treatment of men with erectile dysfunction in Taiwan. Int J Impot Res. 2001;13:221-229 [PMID: 11494079]
58. Boulton AJ, Selam JL, Sweeney M, Ziegler D. Sildenafil citrate for the treatment of erectile dysfunction in men with Type II diabetes mellitus. Diabetologia. 2001;44:1296-1301 [PMID: 11692178] (Pubitemid 33010506)
59. Hussain IF, Brady CM, Swinn MJ, Mathias CJ, Fowler CJ. Treatment of erectile dysfunction with sildenafil citrate (Viagra) in parkinsonism due to Parkinson's disease or multiple system atrophy with observations on orthostatic hypotension. J Neurol Neurosurg Psychiatry. 2001;71:371-374 [PMID: 11511713]
60. Safarinejad MR. Oral sildenafil in the treatment of erectile dysfunction in diabetic men: a randomized double-blind and placebo-controlled study. J Diabetes Complications. 2004;18:205-210 [PMID: 15207837]
61. Webster LJ, Michelakis ED, Davis T, Archer SL. Use of sildenafil for safe improvement of erectile function and quality of life in men with New York Heart Association classes II and III congestive heart failure: a prospective, placebocontrolled, double-blind crossover trial. Arch Intern Med. 2004;164:514-520 [PMID: 15006828] (Pubitemid 38314447)
62. Fowler CJ, Miller JR, Sharief MK, Hussain IF, Stecher VJ, Sweeney M. A double blind, randomised study of sildenafil citrate for erectile dysfunction in men with multiple sclerosis. J Neurol Neurosurg Psychiatry. 2005;76:700-705 [PMID: 15834030] (Pubitemid 40569682)
63. Mahon A, Sidhu PS, Muir G, Macdougall IC. The efficacy of sildenafil for the treatment of erectile dysfunction in male peritoneal dialysis patients. Am J Kidney Dis. 2005;45:381-387 [PMID: 15685517] (Pubitemid 40431065)
64. Katz SD, Parker JD, Glasser DB, Bank AJ, Sherman N, Wang H, et al. Efficacy and safety of sildenafil citrate in men with erectile dysfunction and chronic heart failure. Am J Cardiol. 2005;95:36-42. [PMID: 15619391] (Pubitemid 40051109)
65. Abdel-Naser MB, Imam A, Wollina U. Sildenafil citrate significantly improves nocturnal penile erections in sildenafil non-responding patients with psychogenic erectile dysfunction. Int J Impot Res. 2004;16:552-556 [PMID: 15116063] (Pubitemid 39664867)
66. Tignol J, Furlan PM, Gomez-Beneyto M, Opsomer R, Schreiber W, Sweeney M, et al. Efficacy of sildenafil citrate (Viagra) for the treatment of erectile dysfunction in men in remission from depression. Int Clin Psychopharmacol. 2004;19:191-199 [PMID: 15201565] (Pubitemid 38901646)
67. Padma-Nathan H, Stecher VJ, Sweeney M, Orazem J, Tseng LJ, Deriesthal H. Minimal time to successful intercourse after sildenafil citrate: results of a randomized, double-blind, placebo-controlled trial. Urology. 2003;62:400-403 [PMID: 12946731] (Pubitemid 36999855)
68. Seibel I, Poli De Figueiredo CE, Telöken C, Moraes JF. Efficacy of oral sildenafil in hemodialysis patients with erectile dysfunction. J Am Soc Nephrol. 2002;13:2770-2775 [PMID: 12397048] (Pubitemid 35216047)
69. Gómez F, Davila H, Costa A, Acuña A, Wadskier LA, Plua P; Andean Group of Erectile Dysfunction Study. Efficacy and safety of oral sildenafil citrate (Viagra) in the treatment of male erectile dysfunction in Colombia, Ecuador, and Venezuela: a double-blind, multicenter, placebo-controlled study. Int J Impot Res. 2002;14 Suppl 2:S42-7. [PMID: 12161767] (Pubitemid 34947720)
70. Becher E, Tejada Noriega A, Gomez R, Decia R; Southern Latin America Sildenafil Study Group, Buenos Aires, Argentina. Sildenafil citrate (Viagra) in the treatment of men with erectile dysfunction in southern Latin America: a double-blind, randomized, placebo-controlled, parallel-group, multicenter, flexible-dose escalation study. Int J Impot Res. 2002;14 Suppl 2:S33-41. [PMID: 12161766] (Pubitemid 34947719)
71. Lindsey I, George B, Kettlewell M, Mortensen N. Randomized, doubleblind, placebo-controlled trial of sildenafil (Viagra) for erectile dysfunction after rectal excision for cancer and inflammatory bowel disease. Dis Colon Rectum. 2002;45:727-732 [PMID: 12072621] (Pubitemid 34602484)
72. Eardley I, Ellis P, Boolell M, Wulff M. Onset and duration of action of sildenafil for the treatment of erectile dysfunction. Br J Clin Pharmacol. 2002;53 Suppl 1:61S-65S. [PMID: 11879261] (Pubitemid 34226988)
73. Incrocci L, Koper PC, Hop WC, Slob AK. Sildenafil citrate (Viagra) and erectile dysfunction following external beam radiotherapy for prostate cancer: a randomized, double-blind, placebo-controlled, cross-over study. Int J Radiat Oncol Biol Phys. 2001;51:1190-1195 [PMID: 11728676] (Pubitemid 33116310)
74. Olsson AM, Persson CA; Swedish Sildenafil Investigators Group. Efficacy and safety of sildenafil citrate for the treatment of erectile dysfunction in men with cardiovascular disease. Int J Clin Pract. 2001;55:171-176 [PMID: 11351770]
75. Montorsi F, Maga T, Strambi LF, Salonia A, Barbieri L, Scattoni V, et al. Sildenafil taken at bedtime significantly increases nocturnal erections: results of a placebo-controlled study. Urology. 2000;56:906-911 [PMID: 11113728]
76. Cappelleri JC, Siegel RL, Osterloh IH, Rosen RC. Relationship between patient self-assessment of erectile function and the erectile function domain of the international index of erectile function. Urology. 2000;56:477-481 [PMID: 10962319]
77. Montorsi F, McDermott TE, Morgan R, Olsson A, Schultz A, Kirkeby HJ, et al. Efficacy and safety of fixed-dose oral sildenafil in the treatment of erectile dysfunction of various etiologies. Urology. 1999;53:1011-1018 [PMID: 10223498] (Pubitemid 29196320)
78. Dinsmore WW, Hodges M, Hargreaves C, Osterloh IH, Smith MD, Rosen RC. Sildenafil citrate (Viagra) in erectile dysfunction: near normalization in men with broad-spectrum erectile dysfunction compared with age-matched healthy control subjects. Urology. 1999;53:800-805 [PMID: 10197860] (Pubitemid 29163049)
79. Padma-Nathan H, Steers WD, Wicker PA. Efficacy and safety of oral sildenafil in the treatment of erectile dysfunction: a double-blind, placebocontrolled study of 329 patients. Sildenafil Study Group. Int J Clin Pract. 1998; 52:375-379 [PMID: 9894373] (Pubitemid 28451100)
80. Albuquerque DC, Miziara LJ, Saraiva JF, Rodrigues US, Ribeiro AB, Wajngarten M. Efficacy, safety and tolerability of sildenafil in Brazilian hypertensive patients on multiple antihypertensive drugs. Int Braz J Urol. 2005;31:342-53; discussion 354-355 [PMID: 16137403] (Pubitemid 41288442)
81. Gingell C, Sultana SR, Wulff MB, Gepi-Attee S. Duration of action of sildenafil citrate in men with erectile dysfunction. J Sex Med. 2004;1:179-184 [PMID: 16422972] (Pubitemid 40424651)
82. Pickering TG, Shepherd AM, Puddey I, Glasser DB, Orazem J, Sherman N, et al. Sildenafil citrate for erectile dysfunction in men receiving multiple antihypertensive agents: a randomized controlled trial. Am J Hypertens. 2004;17: 1135-1142 [PMID: 15607620] (Pubitemid 40029411)
83. Glina S, Bertero E, Claro J, Damião R, Faria G, Fregnosi A, et al. Efficacy and safety of sildenafil citrate for the treatment of erectile dysfunction in Latin America. Brazilian Journal of Urology. 2001;27:148-154 (Pubitemid 32447883)
84. Heiman JR, Talley DR, Bailen JL, Oskin TA, Rosenberg SJ, Pace CR, et al. Sexual function and satisfaction in heterosexual couples when men are administered sildenafil citrate (Viagra) for erectile dysfunction: a multicentre, randomised, double-blind, placebo-controlled trial. BJOG. 2007;114:437-447 [PMID: 17284249]
85. Sommer F, Klotz T, Engelmann U. Improved spontaneous erectile function in men with mild-to-moderate arteriogenic erectile dysfunction treated with a nightly dose of sildenafil for one year: a randomized trial. Asian J Androl. 2007; 9:134-141 [PMID: 17187165] (Pubitemid 46050228)
86. McVary KT, Monnig W, Camps JL Jr, Young JM, Tseng LJ, van den Ende G. Sildenafil citrate improves erectile function and urinary symptoms in men with erectile dysfunction and lower urinary tract symptoms associated with benign prostatic hyperplasia: a randomized, double-blind trial. J Urol. 2007;177: 1071-1077 [PMID: 17296414] (Pubitemid 46216352)
87. Zinner N. Do food and dose timing affect the efficacy of sildenafil? A randomized placebo-controlled study. J Sex Med. 2007;4:137-144 [PMID: 17233779] (Pubitemid 46002375)
88. Orr G, Weiser M, Polliack M, Raviv G, Tadmor D, Grunhaus L. Effectiveness of sildenafil in treating erectile dysfunction in PTSD patients: a doubleblind, placebo-controlled crossover study. J Clin Psychopharmacol. 2006;26:426-430 [PMID: 16855464] (Pubitemid 44187648)
89. Sharma RK, Prasad N, Gupta A, Kapoor R. Treatment of erectile dysfunction with sildenafil citrate in renal allograft recipients: a randomized, doubleblind, placebo-controlled, crossover trial. Am J Kidney Dis. 2006;48:128-133 [PMID: 16797395] (Pubitemid 43912950)
90. Althof SE, O'Leary MP, Cappelleri JC, Hvidsten K, Stecher VJ, Glina S, et al; International SEAR Study Group. Sildenafil citrate improves self-esteem, confidence, and relationships in men with erectile dysfunction: Results from an international, multi-center, double-blind, placebo-controlled trial. J Sex Med. 2006;3:521-529 [PMID: 16681478]
91. Fava M, Nurnberg HG, Seidman SN, Holloway W, Nicholas S, Tseng LJ, et al. Efficacy and safety of sildenafil in men with serotonergic antidepressantassociated erectile dysfunction: results from a randomized, double-blind, placebocontrolled trial. J Clin Psychiatry. 2006;67:240-246 [PMID: 16566619] (Pubitemid 43357470)
92. Gopalakrishnan R, Jacob KS, Kuruvilla A, Vasantharaj B, John JK. Sildenafil in the treatment of antipsychotic-induced erectile dysfunction: a randomized, double-blind, placebo-controlled, flexible-dose, two-way crossover trial. Am J Psychiatry. 2006;163:494-499 [PMID: 16513872] (Pubitemid 44469393)
93. O'Leary MP, Althof SE, Cappelleri JC, Crowley A, Sherman N, Duttagupta S; United States Self-Esteem and Relationship Questionnaire Study Group. Self-esteem, confidence and relationship satisfaction of men with erectile dysfunction treated with sildenafil citrate: a multicenter, randomized, parallel group, double-blind, placebo controlled study in the United States. J Urol. 2006; 175:1058-1062 [PMID: 16469617] (Pubitemid 43200088)
94. Koulikov D, Fridmans A, Chertin B, Shenfeld O, Farkas A, Spitz IM. Is sildenafil citrate associated with an amelioration of the symptomatology of androgen decline in the aging male? J Urol. 2007;177:2267-2271 [PMID: 17509338]
95. Buranakitjaroen P, Mangklabruks A, Leungwattanakij S, Ngaothamatasn W, Malhotra C, Chee C, et al; Thai-Malaysian-Singapore Erectile Dysfunction Study Group (THAMES Group). Efficacy and safety of sildenafil in Asian males with erectile dysfunction and cardiovascular risk. J Med Assoc Thai. 2007;90: 1100-1108 [PMID: 17624203]
96. Bannowsky A, Schulze H, van der Horst C, Hautmann S, Jünemann KP. Recovery of erectile function after nerve-sparing radical prostatectomy: improvement with nightly low-dose sildenafil. BJU Int. 2008;101:1279-1283 [PMID: 18284406] (Pubitemid 351549634)
97. Hong SK, Han BK, Jeong SJ, Byun SS, Lee SE. Effect of statin therapy on early return of potency after nerve sparing radical retropubic prostatectomy. J Urol. 2007;178:613-616 [PMID: 17570410]
98. Hundertmark J, Esterman A, Ben-Tovim D, Austin MA, Dougherty M. The South Australian couples sildenafil study: double-blind, parallel-group randomized controlled study to examine the psychological and relationship consequences of sildenafil use in couples. J Sex Med. 2007;4:1126-1135 [PMID: 17627725] (Pubitemid 47079607)
99. Kadioglu A, Grohmann W, Depko A, Levinson IP, Sun F, Collins S. Quality of erections in men treated with flexible-dose sildenafil for erectile dysfunction: multicenter trial with a double-blind, randomized, placebo-controlled phase and an open-label phase. J Sex Med. 2008;5:726-734 [PMID: 18086165] (Pubitemid 351337899)
100. Jones LA, Klimberg IW, McMurray JG, Padula R, Tseng LJ, Stecher VJ. Effect of sildenafil citrate on the male sexual experience assessed with the Sexual Experience Questionnaire: a multicenter, double-blind, placebo-controlled trial with open-label extension. J Sex Med. 2008;5:1955-1964 [PMID: 18564150]
101. McCullough AR, Levine LA, Padma-Nathan H. Return of nocturnal erections and erectile function after bilateral nerve-sparing radical prostatectomy in men treated nightly with sildenafil citrate: subanalysis of a longitudinal randomized double-blind placebo-controlled trial. J Sex Med. 2008;5:476-484 [PMID: 18086170]
102. McCullough AR, Steidle CP, Klee B, Tseng LJ. Randomized, doubleblind, crossover trial of sildenafil in men with mild to moderate erectile dysfunction: efficacy at 8 and 12 hours postdose. Urology. 2008;71:686-692 [PMID: 18387397]
103. McCullough AR, Steidle CP, Kaufman J, Goldfischer ER, Klee B, Carlsson M. Sildenafil citrate efficacy 8 h postdose in men with mild to moderate erectile dysfunction. Int J Impot Res. 2008;20:388-395 [PMID: 18528401]
104. Morano S, Mandosi E, Fallarino M, Gatti A, Tiberti C, Sensi M, et al. Antioxidant treatment associated with sildenafil reduces monocyte activation and markers of endothelial damage in patients with diabetic erectile dysfunction: a double-blind, placebo-controlled study. Eur Urol. 2007;52:1768-1774 [PMID: 17478034] (Pubitemid 350052399)
105. Buvat J, Hatzichristou D, Maggi M, Farmer I, Martínez-Jabaloyas JM, Miller PJ, et al. Efficacy, tolerability and satisfaction with sildenafil citrate 100-mg titration compared with continued 50-mg dose treatment in men with erectile dysfunction. BJU Int. 2008;102:1645-1650 [PMID: 18710446]
106. Safarinejad MR. Evaluation of the safety and efficacy of sildenafil citrate for erectile dysfunction in men with multiple sclerosis: a double-blind, placebo controlled, randomized study. J Urol. 2009;181:252-258 [PMID: 19013598]
107. Burnett AL, Strong TD, Trock BJ, Jin L, Bivalacqua TJ, Musicki B. Serum biomarker measurements of endothelial function and oxidative stress after daily dosing of sildenafil in type 2 diabetic men with erectile dysfunction. J Urol. 2009;181:245-251 [PMID: 19013603]
108. Montorsi F, Padma-Nathan H, Buvat J, Schwaibold H, Beneke M, Ulbrich E, et al; Vardenafil Study Group. Earliest time to onset of action leading to successful intercourse with vardenafil determined in an at-home setting: a randomized, double-blind, placebo-controlled trial. J Sex Med. 2004;1:168-178 [PMID: 16422971] (Pubitemid 40424650)
109. Goldstein I, Young JM, Fischer J, Bangerter K, Segerson T, Taylor T; Vardenafil Diabetes Study Group. Vardenafil, a new phosphodiesterase type 5 inhibitor, in the treatment of erectile dysfunction in men with diabetes: a multicenter double-blind placebo-controlled fixed-dose study. Diabetes Care. 2003;26: 777-783 [PMID: 12610037]
110. Valiquette L, Young JM, Moncada I, Porst H, Vézina JG, Stancil BN, et al; Vardenafil Study Group. Sustained efficacy and safety of vardenafil for treatment of erectile dysfunction: a randomized, double-blind, placebo-controlled study. Mayo Clin Proc. 2005;80:1291-1297 [PMID: 16212141]
111. Nehra A, Grantmyre J, Nadel A, Thibonnier M, Brock G. Vardenafil improved patient satisfaction with erectile hardness, orgasmic function and sexual experience in men with erectile dysfunction following nerve sparing radical prostatectomy. J Urol. 2005;173:2067-2071 [PMID: 15879836] (Pubitemid 40675245)
112. Carson CC, Hatzichristou DG, Carrier S, Lording D, Lyngdorf P, Aliotta P, et al; Patient Response with Vardenafil in Slidenafil Non-Responders (PROVEN) Study Group. Erectile response with vardenafil in sildenafil nonresponders: a multicentre, double-blind, 12-week, flexible-dose, placebo-controlled erectile dysfunction clinical trial. BJU Int. 2004;94:1301-1309 [PMID: 15610110]
113. Nagao K, Ishii N, Kamidono S, Osada T; Vardenafil (Levitra) Clinical Trial Group. Safety and efficacy of vardenafil in patients with erectile dysfunction: result of a bridging study in Japan. Int J Urol. 2004;11:515-524 [PMID: 15242361] (Pubitemid 39070739)
114. Stief C, Porst H, Sáenz De Tejada I, Ulbrich E, Beneke M; Vardenafil Study Group. Sustained efficacy and tolerability with vardenafil over 2 years of treatment in men with erectile dysfunction. Int J Clin Pract. 2004;58:230-239 [PMID: 15117088] (Pubitemid 38559518)
115. Hatzichristou D, Montorsi F, Buvat J, Laferriere N, Bandel TJ, Porst H; European Vardenafil Study Group. The efficacy and safety of flexible-dose vardenafil (levitra) in a broad population of European men. Eur Urol. 2004;45:634- 41; discussion 641. [PMID: 15082207]
116. Hellstrom WJ, Gittelman M, Karlin G, Segerson T, Thibonnier M, Taylor T, et al. Vardenafil for treatment of men with erectile dysfunction: efficacy and safety in a randomized, double-blind, placebo-controlled trial. J Androl. 2002;23:763-771 [PMID: 12399521] (Pubitemid 36300965)
117. Stark S, Sachse R, Liedl T, Hensen J, Rohde G, Wensing G, et al. Vardenafil increases penile rigidity and tumescence in men with erectile dysfunction after a single oral dose. Eur Urol. 2001;40:181-8; discussion 189-190 [PMID: 11528196] (Pubitemid 32786105)
118. Porst H, Rosen R, Padma-Nathan H, Goldstein I, Giuliano F, Ulbrich E, et al. The efficacy and tolerability of vardenafil, a new, oral, selective phosphodiesterase type 5 inhibitor, in patients with erectile dysfunction: the first at-home clinical trial. Int J Impot Res. 2001;13:192-199 [PMID: 11494074] (Pubitemid 32743600)
119. Klotz T, Sachse R, Heidrich A, Jockenhövel F, Rohde G, Wensing G, et al. Vardenafil increases penile rigidity and tumescence in erectile dysfunction patients: a RigiScan and pharmacokinetic study. World J Urol. 2001;19:32-39 [PMID: 11289568] (Pubitemid 33777030)
120. van Ahlen H, Wahle K, Kupper W, Yassin A, Reblin T, Neureither M. Safety and efficacy of vardenafil, a selective phosphodiesterase 5 inhibitor, in patients with erectile dysfunction and arterial hypertension treated with multiple antihypertensives. J Sex Med. 2005;2:856-864 [PMID: 16422810]
121. Goldstein I, Fisher WA, Sand M, Rosen RC, Mollen M, Brock G, et al; Vardenafil Study Group. Women's sexual function improves when partners are administered vardenafil for erectile dysfunction: a prospective, randomized, double-blind, placebo-controlled trial. J Sex Med. 2005;2:819-832 [PMID: 16422806] (Pubitemid 41727394)
122. Rosen R, Shabsigh R, Berber M, Assalian P, Menza M, Rodriguez-Vela L, et al; Vardenafil Study Site Investigators. Efficacy and tolerability of vardenafil in men with mild depression and erectile dysfunction: the depression-related improvement with vardenafil for erectile response study. Am J Psychiatry. 2006;163: 79-87. [PMID: 16390893] (Pubitemid 43050107)
123. Edwards D, Hackett G, Collins O, Curram J. Vardenafil improves sexual function and treatment satisfaction in couples affected by erectile dysfunction (ED): a randomized, double-blind, placebo-controlled trial in PDE5 inhibitor-naïve men with ED and their partners. J Sex Med. 2006;3:1028-1036 [PMID: 17100936] (Pubitemid 44644715)
124. Porst H, Sharlip ID, Hatzichristou D, Rubio-Aurioles E, Gittelman M, Stancil BN, et al; Vardenafil Study Group. Extended duration of efficacy of vardenafil when taken 8 hours before intercourse: a randomized, double-blind, placebo-controlled study. Eur Urol. 2006;50:1086-94; discussion 1094-1095 [PMID: 16820261]
125. Mazo E, Gamidov S, Iremashvili V. The effect of vardenafil on endothelial function of brachial and cavernous arteries. Int J Impot Res. 2006;18:464-469 [PMID: 16482199] (Pubitemid 44330297)
126. Ziegler D, Merfort F, van Ahlen H, Yassin A, Reblin T, Neureither M. Efficacy and safety of flexible-dose vardenafil in men with type 1 diabetes and erectile dysfunction. J Sex Med. 2006;3:883-891 [PMID: 16942532] (Pubitemid 44269544)
127. Ishii N, Nagao K, Fujikawa K, Tachibana T, Iwamoto Y, Kamidono S. Vardenafil 20-mg demonstrated superior efficacy to 10-mg in Japanese men with diabetes mellitus suffering from erectile dysfunction. Int J Urol. 2006;13:1066-1072 [PMID: 16903931] (Pubitemid 44125678)
128. Demir E, Balal M, Paydas S, Sertdemir Y, Erken U. Efficacy and safety of vardenafil in renal transplant recipients with erectile dysfunction. Transplant Proc. 2006;38:1379-1381 [PMID: 16797309] (Pubitemid 43912726)
129. Zumbé J, Porst H, Sommer F, Grohmann W, Beneke M, Ulbrich E. Comparable efficacy of once-daily versus on-demand vardenafil in men with mild-to-moderate erectile dysfunction: findings of the RESTORE study. Eur Urol. 2008;54:204-210 [PMID: 18395326]
130. Ralph D, Eardley I, Kell P, Dean J, Hackett G, Collins O, et al. Improvement in erectile function on vardenafil treatment correlates with treatment satisfaction in both patients and their partners. BJU Int. 2007;100:130-136 [PMID: 17488308] (Pubitemid 46878557)
131. Montorsi F, Brock G, Lee J, Shapiro J, Van Poppel H, Graefen M, et al. Effect of nightly versus on-demand vardenafil on recovery of erectile function in men following bilateral nerve-sparing radical prostatectomy. Eur Urol. 2008;54: 924-931 [PMID: 18640769]
132. Tan HM, Chin CM, Chua CB, Gatchalian E, Kongkanand A, Moh CL, et al. Efficacy and tolerability of vardenafil in Asian men with erectile dysfunction. Asian J Androl. 2008;10:495-502. [PMID: 18385912] (Pubitemid 351584126)
133. Miner M, Gilderman L, Bailen J, Cook D, Dawson K, Stanislaus M, et al. Vardenafil in men with stable statin therapy and dyslipidemia. J Sex Med. 2008; 5:1455-1467 [PMID: 18373526] (Pubitemid 351803112)
134. Mirone V, Costa P, Damber JE, Holmes S, Moncada I, Van Ahlen H, et al. An evaluation of an alternative dosing regimen with tadalafil, 3 times/week, for men with erectile dysfunction: SURE study in 14 European countries. Eur Urol. 2005;47:846-54; discussion 854. [PMID: 15925082] (Pubitemid 40745355)
135. Young JM, Feldman RA, Auerbach SM, Kaufman JM, Garcia CS, Shen W, et al. Tadalafil improved erectile function at twenty-four and thirty-six hours after dosing in men with erectile dysfunction: US trial. J Androl. 2005;26:310-318 [PMID: 15866997] (Pubitemid 40628966)
136. McMahon CG, Stuckey BG, Lording DW, Wittert GA, Murphy A, Shin J, et al. A 6-month study of the efficacy and safety of tadalafil in the treatment of erectile dysfunction: a randomised, double-blind, parallel-group, placebocontrolled study in Australian men. Int J Clin Pract. 2005;59:143-149 [PMID: 15854188] (Pubitemid 40331212)
137. Carson C, Shabsigh R, Segal S, Murphy A, Fredlund P, Kuepfer C; Trial Evaluating the Activity of Tadalafil for Erectile Dysfunction-United States (TREATED-US) Study Group. Efficacy, safety, and treatment satisfaction of tadalafil versus placebo in patients with erectile dysfunction evaluated at tertiarycare academic centers. Urology. 2005;65:353-359 [PMID: 15708052]
138. Rosano GM, Aversa A, Vitale C, Fabbri A, Fini M, Spera G. Chronic treatment with tadalafil improves endothelial function in men with increased cardiovascular risk. Eur Urol. 2005;47:214-20; discussion 220-222 [PMID: 15661417] (Pubitemid 40126979)
139. De Rose AF, Gallo F, Carmignani G. Evaluation of sexual activity in patients treated with tadalafil: a randomized prospective placebo-controlled trial. Int J Impot Res. 2005;17:76-79 [PMID: 15510191] (Pubitemid 40299997)
140. Eardley I, Gentile V, Austoni E, Hackett G, Lembo D, Wang C, et al. Efficacy and safety of tadalafil in a Western European population of men with erectile dysfunction. BJU Int. 2004;94:871-877 [PMID: 15476525] (Pubitemid 39472487)
141. Staab A, Tillmann C, Forgue ST, Mackie A, Allerheiligen SR, Rapado J, et al. Population dose-response model for tadalafil in the treatment of male erectile dysfunction. Pharm Res. 2004;21:1463-1470 [PMID: 15359583] (Pubitemid 39149663)
142. Montorsi F, Nathan HP, McCullough A, Brock GB, Broderick G, Ahuja S, et al. Tadalafil in the treatment of erectile dysfunction following bilateral nerve sparing radical retropubic prostatectomy: a randomized, double-blind, placebo controlled trial. J Urol. 2004;172:1036-1041 [PMID: 15311032] (Pubitemid 39096457)
143. Skoumal R, Chen J, Kula K, Breza J, Calomfirescu N, Basson BR, et al. Efficacy and treatment satisfaction with on-demand tadalafil (Cialis) in men with erectile dysfunction. Eur Urol. 2004;46:362-9; discussion 369. [PMID: 15306109] (Pubitemid 39078572)
144. Seftel AD, Wilson SK, Knapp PM, Shin J, Wang WC, Ahuja S. The efficacy and safety of tadalafil in United States and Puerto Rican men with erectile dysfunction. J Urol. 2004;172:652-657 [PMID: 15247754] (Pubitemid 38900228)
145. Porst H, Padma-Nathan H, Giuliano F, Anglin G, Varanese L, Rosen R. Efficacy of tadalafil for the treatment of erectile dysfunction at 24 and 36 hours after dosing: a randomized controlled trial. Urology. 2003;62:121-5; discussion 125-126 [PMID: 12837435] (Pubitemid 36802084)
146. Sáenz de Tejada I, Anglin G, Knight JR, Emmick JT. Effects of tadalafil on erectile dysfunction in men with diabetes. Diabetes Care. 2002;25:2159-2164 [PMID: 12453954] (Pubitemid 41071021)
147. Carrier S, Brock GB, Pommerville PJ, Shin J, Anglin G, Whitaker S, et al. Efficacy and safety of oral tadalafil in the treatment of men in Canada with erectile dysfunction: a randomized, double-blind, parallel, placebo-controlled clinical trial. J Sex Med. 2005;2:685-698 [PMID: 16422827] (Pubitemid 41742929)
148. McMahon C. Comparison of efficacy, safety, and tolerability of on-demand tadalafil and daily dosed tadalafil for the treatment of erectile dysfunction. J Sex Med. 2005;2:415-25; discussion 425-427 [PMID: 16422874] (Pubitemid 40744383)
149. Chen KK, Jiann BP, Lin JS, Lee SS, Huang ST, Wang CJ, et al. Efficacy and safety of on-demand oral tadalafil in the treatment of men with erectile dysfunction in Taiwan: a randomized, double-blind, parallel, placebo-controlled clinical study. J Sex Med. 2004;1:201-208 [PMID: 16422975]
150. Rosen RC, Padma-Nathan H, Shabsigh R, Saikali K, Watkins V, Pullman W. Determining the earliest time within 30 minutes to erectogenic effect after tadalafil 10 and 20 mg: a multicenter, randomized, double-blind, placebo-controlled, at-home study. J Sex Med. 2004;1:193-200. [PMID: 16422974] (Pubitemid 40424653)
151. Aversa A, Greco E, Bruzziches R, Pili M, Rosano G, Spera G. Relationship between chronic tadalafil administration and improvement of endothelial function in men with erectile dysfunction: a pilot study. Int J Impot Res. 2007;19: 200-207 [PMID: 16943794] (Pubitemid 46340840)
152. McVary KT, Roehrborn CG, Kaminetsky JC, Auerbach SM, Wachs B, Young JM, et al. Tadalafil relieves lower urinary tract symptoms secondary to benign prostatic hyperplasia. J Urol. 2007;177:1401-1407 [PMID: 17382741] (Pubitemid 46435965)
153. Saylan M, Khalaf I, Kadioglu A, Shoair KZ, Beheiry A, Wang WC, et al. Efficacy of tadalafil in Egyptian and Turkish men with erectile dysfunction. Int J Clin Pract. 2006;60:812-819 [PMID: 16846400] (Pubitemid 43881155)
154. Rajfer J, Aliotta PJ, Steidle CP, Fitch WP 3rd, Zhao Y, Yu A. Tadalafil dosed once a day in men with erectile dysfunction: a randomized, double-blind, placebo-controlled study in the US. Int J Impot Res. 2007;19:95-103. [PMID: 16871272] (Pubitemid 46067355)
155. Yip WC, Chiang HS, Mendoza JB, Tan HM, Li MK, Wang WC, et al. Efficacy and safety of on demand tadalafil in the treatment of East and Southeast Asian men with erectile dysfunction: a randomized double-blind, parallel, placebo-controlled clinical study. Asian J Androl. 2006;8:685-692 [PMID: 16855765]
156. Guo YL, Zhu JC, Pan TM, Ding Q, Wang YX, Cheong NF, et al. Efficacy and safety of on-demand tadalafil for the treatment of erectile dysfunction in South-East Asian men. Int J Urol. 2006;13:721-727 [PMID: 16834650] (Pubitemid 43926762)
157. Nagao K, Kimoto Y, Marumo K, Tsujimura A, Vail GM, Watts S, et al. Efficacy and safety of tadalafil 5, 10, and 20 mg in Japanese men with erectile dysfunction: results of a multicenter, randomized, double-blind, placebocontrolled study. Urology. 2006;68:845-851 [PMID: 17070365] (Pubitemid 44633378)
158. Incrocci L, Slagter C, Slob AK, Hop WC. A randomized, double-blind, placebo-controlled, cross-over study to assess the efficacy of tadalafil (Cialis) in the treatment of erectile dysfunction following three-dimensional conformal externalbeam radiotherapy for prostatic carcinoma. Int J Radiat Oncol Biol Phys. 2006; 66:439-444 [PMID: 16965992] (Pubitemid 44332743)
159. Choi HK, Kim JJ, Kim SC, Suh J, Park YK, Choi S, et al. A randomised, double-blind, parallel, placebo-controlled study of the efficacy and safety of Tadalafil administered on-demand to men with erectile dysfunction in Korea. Taehan Pinyogikwa Hakhoe Chapchi. 2006;47:852-858 (Pubitemid 44741009)
160. Bocchio M, Pelliccione F, Passaquale G, Mihalca R, Necozione S, Desideri G, et al. Inhibition of phosphodiesterase type 5 with tadalafil is associated to an improved activity of circulating angiogenic cells in men with cardiovascular risk factors and erectile dysfunction. Atherosclerosis. 2008;196:313-319 [PMID: 17150221]
161. Hatzichristou D, Gambla M, Rubio-Aurioles E, Buvat J, Brock GB, Spera G, et al. Efficacy of tadalafil once daily in men with diabetes mellitus and erectile dysfunction. Diabet Med. 2008;25:138-146 [PMID: 18290855] (Pubitemid 351297651)
162. Paick JS, Kim SW, Yang DY, Kim JJ, Lee SW, Ahn TY, et al. The efficacy and safety of udenafil, a new selective phosphodiesterase type 5 inhibitor, in patients with erectile dysfunction. J Sex Med. 2008;5:946-953 [PMID: 18221288]
163. Eardley I, Mirone V, Montorsi F, Ralph D, Kell P, Warner MR, et al. An open-label, multicentre, randomized, crossover study comparing sildenafil citrate and tadalafil for treating erectile dysfunction in men naïve to phosphodiesterase 5 inhibitor therapy. BJU Int. 2005;96:1323-1332 [PMID: 16287454] (Pubitemid 41743933)
164. von Keitz A, Rajfer J, Segal S, Murphy A, Denne J, Costigan T, et al. A multicenter, randomized, double-blind, crossover study to evaluate patient preference between tadalafil and sildenafil. Eur Urol. 2004;45:499-507; discussion 507-509 [PMID: 15041116] (Pubitemid 38376216)
165. Govier F, Potempa AJ, Kaufman J, Denne J, Kovalenko P, Ahuja S. A multicenter, randomized, double-blind, crossover study of patient preference for tadalafil 20 mg or sildenafil citrate 50 mg during initiation of treatment for erectile dysfunction. Clin Ther. 2003;25:2709-2723 [PMID: 14693299] (Pubitemid 37510585)
166. Tolrà JR, Campaña JM, Ciutat LF, Miranda EF. Prospective, randomized, open-label, fixed-dose, crossover study to establish preference of patients with erectile dysfunction after taking the three PDE-5 inhibitors. J Sex Med. 2006;3:901-909 [PMID: 16942534]
167. Paick JS, Ahn TY, Choi HK, Chung WS, Kim JJ, Kim SC, et al. Efficacy and safety of mirodenafil, a new oral phosphodiesterase type 5 inhibitor, for treatment of erectile dysfunction. J Sex Med. 2008;5:2672-2680 [PMID: 18638004]
168. Paick JS, Choi HK, Kim SC, Ahn TY, Kim JJ, Park JK, et al. Efficacy and safety of oral SK3530 for the treatment of erectile dysfunction in Korean men: a multicenter, randomized, double-blind, placebo-controlled, fixed dose, parallel group clinical trial. Asian J Androl. 2008;10:791-798 [PMID: 18645683]
169. Cavallini G, Modenini F, Vitali G, Koverech A. Acetyl-L-carnitine plus propionyl-L-carnitine improve efficacy of sildenafil in treatment of erectile dysfunction after bilateral nerve-sparing radical retropubic prostatectomy. Urology. 2005;66:1080-1085 [PMID: 16286128] (Pubitemid 41587165)
170. Perimenis P, Markou S, Gyftopoulos K, Giannitsas K, Athanasopoulos A, Liatsikos E, et al. Efficacy of apomorphine and sildenafil in men with nonarteriogenic erectile dysfunction. A comparative crossover study. Andrologia. 2004;36:106-110 [PMID: 15206909]
171. Eardley I, Wright P, MacDonagh R, Hole J, Edwards A. An open-label, randomized, flexible-dose, crossover study to assess the comparative efficacy and safety of sildenafil citrate and apomorphine hydrochloride in men with erectile dysfunction. BJU Int. 2004;93:1271-1275 [PMID: 15180621] (Pubitemid 38823951)
172. Perimenis P, Gyftopoulos K, Giannitsas K, Markou SA, Tsota I, Chrysanthopoulou A, et al. A comparative, crossover study of the efficacy and safety of sildenafil and apomorphine in men with evidence of arteriogenic erectile dysfunction. Int J Impot Res. 2004;16:2-7. [PMID: 14963464] (Pubitemid 38401552)
173. Pavone C, Curto F, Anello G, Serretta V, Almasio PL, Pavone-Macaluso M. Prospective, randomized, crossover comparison of sublingual apomorphine (3 mg) with oral sildenafil (50 mg) for male erectile dysfunction. J Urol. 2004;172: 2347-2349 [PMID: 15538264] (Pubitemid 39507524)
174. Porst H, Behre HM, Jungwirth A, Burkart M. Comparative trial of treatment satisfaction, efficacy and tolerability of sildenafil versus apomorphine in erectile dysfunction-an open, randomized cross-over study with flexible dosing. Eur J Med Res. 2007;12:61-67 [PMID: 17369119] (Pubitemid 46394640)
175. Melnik T, Abdo CH. Psychogenic erectile dysfunction: comparative study of three therapeutic approaches. J Sex Marital Ther. 2005;31:243-255 [PMID: 16020142] (Pubitemid 40594095)
176. Perimenis P, Karkoulias K, Konstantinopoulos A, Perimeni PP, Katsenis G, Athanasopoulos A, et al. Sildenafil versus continuous positive airway pressure for erectile dysfunction in men with obstructive sleep apnea: a comparative study of their efficacy and safety and the patient's satisfaction with treatment. Asian J Androl. 2007;9:259-264 [PMID: 17334593] (Pubitemid 46416589)
177. Ugarte F, Hurtado-Coll A. Comparison of the efficacy and safety of sildenafil citrate (Viagra) and oral phentolamine for the treatment of erectile dysfunction. Int J Impot Res. 2002;14 Suppl 2:S48-53. [PMID: 12161768] (Pubitemid 34947721)
178. Choppin A, Blue DR, Hegde SS, Gennevois D, McKinnon SA, Mokatrin A, et al. Evaluation of oral ro70-0004/003, an alpha1A-adrenoceptor antagonist, in the treatment of male erectile dysfunction. Int J Impot Res. 2001;13:157-161 [PMID: 11525314] (Pubitemid 32587262)
179. Kaplan SA, Gonzalez RR, Te AE. Combination of alfuzosin and sildenafil is superior to monotherapy in treating lower urinary tract symptoms and erectile dysfunction. Eur Urol. 2007;51:1717-1723 [PMID: 17258855]
180. Diamond LE, Earle DC, Garcia WD, Spana C. Co-administration of low doses of intranasal PT-141, a melanocortin receptor agonist, and sildenafil to men with erectile dysfunction results in an enhanced erectile response. Urology. 2005; 65:755-759 [PMID: 15833522] (Pubitemid 40523013)
181. Gentile V, Vicini P, Prigiotti G, Koverech A, Di Silverio F. Preliminary observations on the use of propionyl-L-carnitine in combination with sildenafil in patients with erectile dysfunction and diabetes. Curr Med Res Opin. 2004;20: 1377-1384 [PMID: 15383186] (Pubitemid 39361341)
182. Dunzendorfer U, Behm A, Dunzendorfer E, Dunzendorfer A. Drug combinations in the therapy of low response to phosphodiesterase 5 inhibitors in patients with erectile dysfunction. In Vivo. 2002;16:345-348 [PMID: 12494876] (Pubitemid 35460387)
183. Bank AJ, Kelly AS, Kaiser DR, Crawford WW, Waxman B, Schow DA, et al. The effects of quinapril and atorvastatin on the responsiveness to sildenafil in men with erectile dysfunction. Vasc Med. 2006;11:251-257 [PMID: 17390549] (Pubitemid 46470504)
184. Safarinejad MR. Salvage of sildenafil failures with cabergoline: a randomized, double-blind, placebo-controlled study. Int J Impot Res. 2006;18:550-558 [PMID: 16625231]
185. Herrmann HC, Levine LA, Macaluso J Jr, Walsh M, Bradbury D, Schwartz S, et al. Can atorvastatin improve the response to sildenafil in men with erectile dysfunction not initially responsive to sildenafil? Hypothesis and pilot trial results. J Sex Med. 2006;3:303-308 [PMID: 16490024]
186. Haren M, Chapman I, Coates P, Morley J, Wittert G. Effect of 12 month oral testosterone on testosterone deficiency symptoms in symptomatic elderly males with low-normal gonadal status. Age Ageing. 2005;34:125-130 [PMID: 15596419] (Pubitemid 40331092)
187. Seftel AD, Mack RJ, Secrest AR, Smith TM. Restorative increases in serum testosterone levels are significantly correlated to improvements in sexual functioning. J Androl. 2004;25:963-972 [PMID: 15477371]
188. Shabsigh R, Kaufman JM, Steidle C, Padma-Nathan H. Randomized study of testosterone gel as adjunctive therapy to sildenafil in hypogonadal men with erectile dysfunction who do not respond to sildenafil alone. J Urol. 2004; 172:658-663 [PMID: 15247755] (Pubitemid 38900229)
189. Cavallini G, Caracciolo S, Vitali G, Modenini F, Biagiotti G. Carnitine versus androgen administration in the treatment of sexual dysfunction, depressed mood, and fatigue associated with male aging. Urology. 2004;63:641-646 [PMID: 15072869] (Pubitemid 38479399)
190. Aversa A, Isidori AM, Spera G, Lenzi A, Fabbri A. Androgens improve cavernous vasodilation and response to sildenafil in patients with erectile dysfunction. Clin Endocrinol (Oxf). 2003;58:632-638 [PMID: 12699447] (Pubitemid 36566807)
191. Clopper RR, Voorhess ML, MacGillivray MH, Lee PA, Mills B. Psychosexual behavior in hypopituitary men: a controlled comparison of gonadotropin and testosterone replacement. Psychoneuroendocrinology. 1993;18:149-161 [PMID: 8493299] (Pubitemid 23096426)
192. Boyanov MA, Boneva Z, Christov VG. Testosterone supplementation in men with type 2 diabetes, visceral obesity and partial androgen deficiency. Aging Male. 2003;6:1-7. [PMID: 12809074] (Pubitemid 36606394)
193. Rabkin JG, Wagner GJ, Rabkin R. A double-blind, placebo-controlled trial of testosterone therapy for HIV-positive men with hypogonadal symptoms. Arch Gen Psychiatry. 2000;57:141-7; discussion 155-156 [PMID: 10665616] (Pubitemid 30075264)
194. Shamloul R, Ghanem H, Fahmy I, El-Meleigy A, Ashoor S, Elnashaar A, et al. Testosterone therapy can enhance erectile function response to sildenafil in patients with PADAM: a pilot study. J Sex Med. 2005;2:559-564 [PMID: 16422854] (Pubitemid 40975841)
195. Schiavi RC, White D, Mandeli J, Levine AC. Effect of testosterone administration on sexual behavior and mood in men with erectile dysfunction. Arch Sex Behav. 1997;26:231-241 [PMID: 9146812] (Pubitemid 27188130)
196. Yassin AA, Saad F, Diede HE. Testosterone and erectile function in hypogonadal men unresponsive to tadalafil: results from an open-label uncontrolled study. Andrologia. 2006;38:61-68 [PMID: 16529577]
197. Seidman SN, Roose SP. The sexual effects of testosterone replacement in depressed men: randomized, placebo-controlled clinical trial. J Sex Marital Ther. 2006;32:267-273 [PMID: 16809253]
198. Gomaa AA, Hamed HA. Improvement of sexual function in partial testosterone-deficient ageing men treated with cream containing testosterone and vasoactive agents. J Mens Health Gend. 2006;3:47-55.
199. Merza Z, Blumsohn A, Mah PM, Meads DM, McKenna SP, Wylie K, et al. Double-blind placebo-controlled study of testosterone patch therapy on bone turnover in men with borderline hypogonadism. Int J Androl. 2006;29: 381-391 [PMID: 16390499] (Pubitemid 43736299)
200. Chiang HS, Hwang TI, Hsui YS, Lin YC, Chen HE, Chen GC, et al. Transdermal testosterone gel increases serum testosterone levels in hypogonadal men in Taiwan with improvements in sexual function. Int J Impot Res. 2007; 19:411-417 [PMID: 17538639]
201. Margo CE, French DD. Ischemic optic neuropathy in male veterans prescribed phosphodiesterase-5 inhibitors. Am J Ophthalmol. 2007;143:538-539 [PMID: 17317413]
202. McEvoy GK. AHFS Drug Information. Bethesda, MD: American Soc of Health-System Pharmacists; 2008.